检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:武国军[1] 李晓武[1] 朱李兵[1] 王禾[1] 袁建林[1] 于磊[1] 张更[1] 王立国[1] 刘贺亮[1]
机构地区:[1]第四军医大学西京医院泌尿外科,陕西西安710032
出 处:《中国现代医学杂志》2009年第17期2619-2622,共4页China Journal of Modern Medicine
基 金:军队医药卫生"十一五"科研项目(No:06H040);第四军医大学优秀博士学位论文课题资助项目
摘 要:目的利用与临床Gleason分级系统相近的小鼠组织学分级系统分析比较基因敲入(KIMAP)和转基因(TGMAP)小鼠前列腺癌模型。方法依照前列腺癌临床诊断的Gleason五级10分制的组织学分级和评分标准,建立了基因工程小鼠模型的分析标准。对96例KIMAP和44例TGMAP前列腺癌标本进行了分析,并与临床前列腺癌进行了比较。结果来源于TGMAP(n=前列腺癌44例/总数187例)和KIMAP(n=前列腺癌96例/总数169例)的前列腺癌小鼠表现了不同的组织学评分的分布(P=0.000)。KIMAP小鼠(52.1%)比TGMAP小鼠(25.0%)表现出更高的混合组织学评分率,更接近于临床平均值(50.0%),而TGMAP小鼠在所有年龄组均显示出不平衡的和随意的组织学评分分布。结论由于KIMAP模型成功地模仿了人类前列腺癌特征,在前列腺癌临床前期研究中具有潜在的应用价值。[ Objective ] This study used a new mouse histological grading system similar to the human Gleason grading system to measure and compare the new knock-in mouse adenocarcinoma prostate model (KIMAP) with transgenic mouse adenocarcinoma prostate model (TGMAP) and human prostate cancer (CAP). [ Methods ] According to heterogeneity of the clinical standard for prostate cancer diagnosis, a close-to-human mouse standard for histological grading and scoring system, Gleason analogous grading system, was established in this study. 96 K/MAP and 44 TGMAP prostate cancer samples were measured and compared with human CaP. [Results] Mice with CaP from TGMAP (n =CaP 44/total 187) and K/MAP (n =CaP 96/total 169) models showed a different distribution of histologi- cal scores (P =0.000). K/MAP mice showed higher percentage (52.1%) of compound histological score rate than TGMAP (25.0%), but closer to the clinical average (50.0%), while TGMAP mice revealed unbalanced and random score distribution in all age groups. [ Conclusion ] Due to the effective mimicry of human CaP tumors demonstrated by the KIMAP model, this study advocates its use in the clinical study of human CaP
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.15